Abstract

Progression of chronic myelogenous leukemia (CML) is frequently accompanied by cytogenetic evolution. Additional genetic abnormalities are seen in 10–20% of CML cases at the time of diagnosis, and in 60–80% of cases of advanced disease. Unbalanced chromosomal changes such as an extra copy of the Philadelphia chromosome (Ph), trisomy 8, and i(17)(q10) are common. Balanced chromosomal translocations, such as t(3;3), t(8;21), t(15;17), and inv(16) are typically found in acute myeloid leukemia, but rarely occur in CML. Translocations involving 11q23, t(8;21), and inv(16) are relatively common genetic abnormalities in acute leukemia, but are extremely rare in CML. In the literature to date, there are at least 76 Ph+ cases with t(3;21), 47 Ph+ cases with inv(16), 16 Ph+ cases with t(8;21), and 9 Ph+ cases with t(9;11). But most of what has been published is now over 30 years old, without the benefit of modern immunophenotyping to confirm diagnosis, and before the introduction of treatment regimes such as TKI. In this study, we explored the rare concomitant occurrence of coexistence current chromosomal translocation and t(9;22) in CML or acute myeloid leukemia (AML).

Highlights

  • The prognostic significance of clonal evolution in chronic myelogenous leukemia (CML) is variable and depends on many factors, including the type of cytogenetic changes, the time and phase of emergence of clonal evolution, and other chromosomal abnormalities [1,2,3]

  • Cytogenetic evidence of clonal evolution in CML is common as the disease progresses to accelerated or blast phase, its impact is dependent on the specific chromosomal anomalies [4]

  • Three of the five patients were newly diagnosed with chronic myelogenous leukemia, and all relapsed after imatinib treatment

Read more

Summary

Introduction

The prognostic significance of clonal evolution in CML is variable and depends on many factors, including the type of cytogenetic changes, the time and phase of emergence of clonal evolution, and other chromosomal abnormalities [1,2,3]. Cytogenetic evidence of clonal evolution in CML is common as the disease progresses to accelerated or blast phase, its impact is dependent on the specific chromosomal anomalies [4]. The coexistence of t(9; 22)(q34;q11.2) and recurrent chromosomal abnormalities is extremely uncommon, especially t(9;11) and t(3;21). We have characterized 5 cases of hematologic malignancy exhibiting coexistence of t(9;22) and recurrent chromosomal abnormalities, including two cases of t(9;11) and one case each of t(3;21), t(8;21) and inv(16)

Methods
Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call